GMRE
Global Medical REIT Inc. Real Estate - REIT - Healthcare Facilities Investor Relations →
Global Medical REIT Inc. (GMRE) closed at $32.38 as of 2026-03-20, trading 5.7% below its 200-week moving average of $34.33. This places GMRE in the deep value zone. The stock is currently moving closer to the line, down from -3.0% last week. The 14-week RSI sits at 44, indicating neutral momentum.
Trading volume is running at 1.8x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.80 ratio) is neutral — neither side is clearly dominating.
Over the past 617 weeks of data, GMRE has crossed below its 200-week moving average 6 times. On average, these episodes lasted 56 weeks. The average one-year return after crossing below was -25.4%, suggesting these dips have not historically been reliable buying opportunities for this stock.
With a market cap of $980 million, GMRE is a small-cap stock. The company generates a free cash flow yield of 6.7%, which is healthy. Return on equity stands at 0.4%. The stock trades at 1.2x book value.
This stock also meets the Yartseva multibagger criteria as a small-cap with strong free cash flow yield and reasonable book value.
Over the past 11.9 years, a hypothetical investment of $100 in GMRE would have grown to $157, compared to $413 for the S&P 500. GMRE has returned 3.8% annualized vs 12.6% for the index, underperforming the broader market over this period.
In the past 12 months, corporate insiders have made 6 open-market purchases totaling $2,010,957. Multiple insiders purchased within a 30-day window — a cluster buy pattern that historically signals management confidence in the company's prospects. Notably, these purchases occurred while GMRE is trading below its 200-week moving average — insiders are buying when the market is most pessimistic.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: GMRE vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After GMRE Crosses Below the Line?
Across 5 historical episodes, buying GMRE when it crossed below its 200-week moving average produced an average return of -24.8% after 12 months (median -13.0%), compared to +18.2% for the S&P 500 over the same periods. After 24 months, the average return was -18.0% vs +39.0% for the index.
Each line shows $100 invested at the moment GMRE crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
GMRE has crossed below its 200-week MA 6 times with an average 1-year return of +-25.4% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| May 2014 | May 2017 | 153 | 97.8% | -72.6% | +56.8% |
| Jun 2022 | Jul 2022 | 5 | 5.6% | -4.9% | -9.5% |
| Aug 2022 | Dec 2023 | 68 | 35.2% | -9.4% | -14.0% |
| Jan 2024 | Jan 2026 | 103 | 30.8% | -14.8% | -17.2% |
| Jan 2026 | Feb 2026 | 1 | 1.4% | N/A | -5.6% |
| Feb 2026 | Ongoing | 4+ | 5.7% | Ongoing | -5.8% |
| Average | 56 | — | +-25.4% | — |
Frequently Asked Questions
Is GMRE below its 200-week moving average?
Yes. As of 2026-03-20, Global Medical REIT Inc. (GMRE) is trading 5.7% below its 200-week moving average of $34.33. The current price is $32.38.
What is GMRE's 200-week moving average price?
Global Medical REIT Inc.'s 200-week moving average is $34.33 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when GMRE drops below its 200-week moving average?
GMRE has crossed below its 200-week moving average 6 times in our data. The average one-year return after these crossings was -25.4%, meaning the dips were not reliable buying signals for this particular stock. These episodes lasted 56 weeks on average.
Is GMRE a good value right now?
Here's what our data says about GMRE as of 2026-03-20: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 44. Free cash flow yield is 6.7%. Return on equity is 0.4%. Price-to-book is 1.2x. This is not a buy or sell recommendation — always do your own research.
How does GMRE compare to the S&P 500?
Over the past 11.9 years, $100 invested in GMRE would have grown to $157, compared to $413 for the S&P 500. That's 3.8% annualized vs 12.6% for the index. GMRE has underperformed the broader market over this period.
Does GMRE pay a dividend?
Yes. Global Medical REIT Inc. currently pays a dividend yield of 8.36%.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20